LataMed AI Corp. (OTC: LMED) announced on June 11, 2026, that it has initiated an operational, technical, and commercial evaluation to potentially integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later platform in Venezuela. The initiative aims to reduce upfront financial barriers for patients seeking private healthcare services, including consultations, diagnostics, wellness programs, and other offerings within the LataMed AI ecosystem.
Management believes that improving payment accessibility could enhance patient engagement, increase healthcare utilization, and drive stronger adoption of the company's platform. By addressing affordability challenges, LataMed AI aims to strengthen its position as a technology-enabled healthcare marketplace serving patients, providers, and partners throughout Latin America. The company expects that a successful integration with Cashea could support its broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a more scalable healthcare marketplace.
Dr. Kevin Rodan Levy, CEO of LataMed AI, stated: "We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem. We believe initiatives such as this have the potential to strengthen patient acquisition, improve engagement, and support long-term platform growth."
LataMed AI has not entered into a definitive commercial agreement as of the release date. Completion of any integration remains subject to further discussions, technical requirements, regulatory review, and customary business conditions. The company intends to provide updates as material developments occur. For additional information, visit https://latamed.ai or review filings with the SEC at www.sec.gov.
